• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [25270 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2025     Norwegian Medical Products Agency (NOMA) [Magnetic resonance guided high-intensity focused ultrasound for treatment of essential tremor: single technology assessment]
2025     Norwegian Medical Products Agency (NOMA) [A leadless pacemaker, MicraTM Transcatheter Pacing System, in (sub-groups of) patients with indication for single-chamber ventricular pacing: a single technology re-assessment]
2025     Health Information and Quality Authority (HIQA) Protocol for a health technology assessment of teledermatology to support the management of primary care referrals
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [SSRI / SSNRI: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tricyclic antidepressants: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Agility training: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Anticonvulsants: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Strength training: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Endurance training: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cognitive behavioural therapy: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cognitive behavioural therapy for insomnia: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Mindfulness-based stress reduction: Evidence report for the S3 guideline on the definition, causes, diagnosis and treatment of fibromyalgia syndrome]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Consumer health information on lung cancer screening using low-dose computed tomography]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Consumer health information on smoking cessation options]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relationship between volume of services and quality of treatment outcome for implantation of unicondylar sled prosthesis - Update of Project V21-02]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relationship between volume of services and quality of treatment outcome in knee replacement revision surgery - Update of Project V21-03]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relationship between volume of services and quality of treatment outcome for total knee replacement – Update of Project V21-01]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Scientific evaluation of the relationship between volume of services and quality of treatment outcome for rare diseases]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of cardiac magnetic resonance imaging in coronary heart disease]
2025     Norwegian Medical Products Agency (NOMA) Intravenous ketamine for treatment-resistant depression
2025     Belgian Health Care Knowledge Centre (KCE) Economic evaluation of whole genome sequencing for children with developmental disorders (Study 2024-09)
2025     Belgian Health Care Knowledge Centre (KCE) Update of prostate cancer screening recommendations (Study 2024-10)
2025     Belgian Health Care Knowledge Centre (KCE) Update of breast cancer screening recommendations (Study 2024-11)
2025     Belgian Health Care Knowledge Centre (KCE) Evaluation of novel blood-based brain biomarkers for mild traumatic brain injuries (Study 2023-11)
2025     Health Information and Quality Authority (HIQA) HTA of providing a telephone service for acute, non-urgent medical care needs in the pre-hospital setting
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Early detection of graft damage in kidney and heart recipient patients using donor-derived free DNA (dd-cfDNA)]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Branched endovascular prostheses for the treatment of aortic arch pathology]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Safety and clinical effectiveness of cryoanalgesia in pediatric patients after surgical intervention for pectus excavatum]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness of care models based on the incorporation of psychologists in primary care]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Diagnostic accuracy of ex vivo confocal microscopy during Mohs surgery for basal cell carcinomas]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical practice guideline (CPG) update palliative care]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical practice guideline on deprescribing antidepressants]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Efficacy and safety of pulmonary balloon angioplasty in the treatment of chronic thromboembolic pulmonary hypertension]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Monitoring study protocol: left ventricular assist devices destination therapy
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Adaptive deep brain stimulation in Parkinson's disease]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Assesment of artificial intelligence´s diagnostic yield and security in cardiac monitoring using insertable cardiac monitors]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [SSRI/SSNRI: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cognitive behavioural therapy: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Gabapentin: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Clonidine: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cimicifuga: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions]
2025     Scottish Health Technologies Group (SHTG) Artificial intelligence-assisted clinician review of chest X-rays for suspected lung cancer
2025     Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for the treatment of people with symptomatic severe aortic stenosis who are at low surgical risk
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Relationship between volume of services and quality of treatment outcome for major liver resection]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Irradiation of the skin with intense pulsed light and radiofrequency for stage I and II hidradenitis suppurativa (Hurley Score)]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of a decision aid for aortic aneurysm interventions]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Early detection of colorectal cancer in people with a family risk]
2025     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guideline synopsis for the update of the DMP "Rheumatoid Arthritis“]
2025     Swiss Federal Office of Public Health (FOPH) Multigene-expression tests for breast cancer
2025     Swiss Federal Office of Public Health (FOPH) Point-of-care diagnostic tests
2025     Swiss Federal Office of Public Health (FOPH) Magnesium supplements for muscle cramps and for the prevention of recurrent urinary tract stones
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Safety and effectiveness of non-invasive management of pectus excavatum with vacuum bell therapy]
2025     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Effectiveness and complications of preimplantation genetic testing for aneuploidies (PGT-A) in in vitro fertilisation (IVF)]
2025     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Interventions to prevent and reduce coercive measures in psychiatric care and residential care for children and young people]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Intraoperative radiation therapy for breast cancer]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness and safety of phalloplasty as a masculinizing genital surgery: a systematic review]
2025     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Occupational exposures and asthma and COPD]
2025     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Adaptive deep brain stimulation in Parkinson's disease]
2025     NIHR Health Technology Assessment programme Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis
2024     Ontario Health Robotic-assisted surgery for rectal cancer: an expedited summary of the clinical evidence
2024     Institute of Health Economics (IHE) Sacral nerve stimulation for the treatment of fecal incontinence
2024     Institute of Health Economics (IHE) Integrating non-physician assessors into the healthcare system for assessment of musculoskeletal conditions
2024     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Tumor-agnostic biomarkers in oncology: a review of diagnostic and therapeutic management]
2024     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Safety, effectiveness and efficiency of resuscitative endovascular balloon occlusión of the aorta (REBOA)]
2024     Agencia de Evaluacion de Tecnologias Sanitarias (AETS-ISCIII) [Efficacy and effectiveness evaluation of transcutaneous capnography in patients with chronic obstructive respiratory disease with hypercapnia in primary care]
2024     Agency for Healthcare Research and Quality (AHRQ) Use of life cycle assessment in the healthcare industry: environmental impacts and emissions associated with products, processes, and waste
2024     Agency for Healthcare Research and Quality (AHRQ) Treatment of stage I-III squamous cell anal cancer
2024     Agency for Healthcare Research and Quality (AHRQ) The effect of protein intake on health: a systematic review
2024     Agency for Healthcare Research and Quality (AHRQ) The association between outcomes and dental services in persons with autoimmune disease treated with biologics and other immunosuppressants: a rapid response review
2024     Agency for Healthcare Research and Quality (AHRQ) Respectful maternity care
2024     Agency for Healthcare Research and Quality (AHRQ) Reducing adverse drug events related to anticoagulant use in adults
2024     Agency for Healthcare Research and Quality (AHRQ) Prevention in adults of transmission of infection with multidrug-resistant organisms
2024     Agency for Healthcare Research and Quality (AHRQ) Pharmacologic and nonpharmacologic treatments for posttraumatic stress disorder: 2024 update of the evidence base for the PTSD trials standardized data repository
2024     Agency for Healthcare Research and Quality (AHRQ) Patient safety practices focused on sepsis prediction and recognition
2024     Agency for Healthcare Research and Quality (AHRQ) Nonpharmacologic treatments for maternal mental health conditions
2024     Agency for Healthcare Research and Quality (AHRQ) Measuring primary healthcare spending
2024     Agency for Healthcare Research and Quality (AHRQ) Measuring documentation burden in healthcare
2024     Agency for Healthcare Research and Quality (AHRQ) Making healthcare safer IV: patient monitoring systems to prevent failure to rescue
2024     Agency for Healthcare Research and Quality (AHRQ) Long COVID models of care
2024     Agency for Healthcare Research and Quality (AHRQ) Linking dental services to treatment outcomes for diabetes: a rapid response review
2024     Agency for Healthcare Research and Quality (AHRQ) Linking dental services to treatment outcomes for chronic kidney disease: a rapid response review
2024     Agency for Healthcare Research and Quality (AHRQ) Healthcare delivery of clinical preventive services for people with disabilities
2024     Agency for Healthcare Research and Quality (AHRQ) Genitourinary syndrome of menopause: a systematic review
2024     Agency for Healthcare Research and Quality (AHRQ) Fatigue and sleepiness of clinicians due to hours of service
2024     Agency for Healthcare Research and Quality (AHRQ) Failure to rescue: rapid response systems
2024     Agency for Healthcare Research and Quality (AHRQ) Evidence map on home- and community-based services and person-centered care for older adults
2024     Agency for Healthcare Research and Quality (AHRQ) Evaluation of dietary protein and amino acid requirements: a systematic review
2024     Agency for Healthcare Research and Quality (AHRQ) Engaging family caregivers with structured communication for safe care transitions
2024     Agency for Healthcare Research and Quality (AHRQ) Diagnosis and treatment of tethered spinal cord
2024     Agency for Healthcare Research and Quality (AHRQ) Diagnosis and management of obsessive compulsive disorders in children
2024     Agency for Healthcare Research and Quality (AHRQ) Deprescribing to reduce medication harms in older adults
2024     Agency for Healthcare Research and Quality (AHRQ) Dental care for people with sickle cell disease: a rapid response literature review
2024     Agency for Healthcare Research and Quality (AHRQ) Dental care for people with hemophilia: a rapid response literature review
2024     Agency for Healthcare Research and Quality (AHRQ) Computerized clinical decision support to prevent medication errors and adverse drug events
2024     Agency for Healthcare Research and Quality (AHRQ) Behavioral interventions for migraine prevention
2024     Agency for Healthcare Research and Quality (AHRQ) Adverse events associated with COVID-19 pharmaceutical treatments
2024     Agency for Healthcare Research and Quality (AHRQ) ADHD diagnosis and treatment in children and adolescents
2024     Agency for Healthcare Research and Quality (AHRQ) Active surveillance culturing of clostridioides difficile and multidrug-resistant organisms: methicillin-resistant staphylococcus aureus, carbapenem-resistant enterobacterales, and candida auris
2024     Center for Drug Evaluation (CDE) [HTA Rapid report-Yervoy (renal cell carcinoma - RCC)]
2024     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on the management of stroke in primary care]